Back to Search
Start Over
Saccharomyces cerevisiae-based mutational analysis of the bc1 complex Qo site residue 279 to study the trade-off between atovaquone resistance and function.
- Source :
-
Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2015 Jul; Vol. 59 (7), pp. 4053-8. Date of Electronic Publication: 2015 Apr 27. - Publication Year :
- 2015
-
Abstract
- The bc1 complex is central to mitochondrial bioenergetics and the target of the antimalarial drug atovaquone that binds in the quinol oxidation (Qo) site of the complex. Structural analysis has shown that the Qo site residue Y279 (Y268 in Plasmodium falciparum) is key for atovaquone binding. Consequently, atovaquone resistance can be acquired by mutation of that residue. In addition to the probability of amino acid substitution, the level of atovaquone resistance and the loss of bc1 complex activity that are associated with the novel amino acid would restrict the nature of resistance-driven mutations occurring on atovaquone exposure in native parasite populations. Using the yeast model, we characterized the effect of all the amino acid replacements resulting from a single nucleotide substitution at codon 279: Y279C, Y279D, Y279F, Y279H, Y279N, and Y279S (Y279C, D, F, H, N, and S). Two residue changes that required a double nucleotide substitution, Y279A and W, were added to the series. We found that mutations Y279A, C, and S conferred high atovaquone resistance but decreased the catalytic activity. Y279F had wild-type enzymatic activity and sensitivity to atovaquone, while the other substitutions caused a dramatic respiratory defect. The results obtained with the yeast model were examined in regard to atomic structure and compared to the reported data on the evolution of acquired atovaquone resistance in P. falciparum.<br /> (Copyright © 2015, American Society for Microbiology. All Rights Reserved.)
- Subjects :
- Amino Acid Substitution
Biological Evolution
Catalysis
Codon genetics
DNA Mutational Analysis
Drug Resistance genetics
Electron Transport Complex III drug effects
Electron Transport Complex III metabolism
Ligands
Models, Molecular
Mutation
Oxidation-Reduction
Plasmodium falciparum drug effects
Plasmodium falciparum genetics
Antimalarials pharmacology
Atovaquone pharmacology
Electron Transport Complex III genetics
Hydroquinones chemistry
Saccharomyces cerevisiae drug effects
Saccharomyces cerevisiae genetics
Subjects
Details
- Language :
- English
- ISSN :
- 1098-6596
- Volume :
- 59
- Issue :
- 7
- Database :
- MEDLINE
- Journal :
- Antimicrobial agents and chemotherapy
- Publication Type :
- Academic Journal
- Accession number :
- 25918152
- Full Text :
- https://doi.org/10.1128/AAC.00710-15